# Targeting Autophagy for Pituitary Tumors

**Authors:** Evan Yin, Motoyasu Satou, Toru Tateno

PMC · DOI: 10.3390/cancers17091402 · Cancers · 2025-04-23

## TL;DR

This review explores how targeting autophagy, a cellular recycling process, could offer new treatments for pituitary tumors, which disrupt hormone levels.

## Contribution

The paper provides a comprehensive review of autophagy's dual role in suppressing or promoting pituitary tumor growth and its potential as a therapeutic target.

## Key findings

- Autophagy can act as both a tumor suppressor and promoter in pituitary tumors.
- Therapeutic strategies to either enhance or inhibit autophagy are being explored for treating these tumors.
- Challenges remain in measuring autophagy activity and understanding its interaction with hormone regulation.

## Abstract

Pituitary tumors are abnormal growths on the pituitary gland, which regulates the body’s hormones. These tumors can disrupt hormone levels, causing various health issues. This review focuses on autophagy, a process where cells recycle and break down their components, and its role in pituitary tumors. Autophagy can either suppress or promote tumor growth, depending on the situation. The review explores different types of autophagy and their effects on tumor development and hormone imbalances. Researchers are investigating whether drugs that target autophagy could be used to treat pituitary tumors. Some drugs aim to boost autophagy, while others work to suppress it. However, measuring autophagy’s activity and understanding its relationship with hormone production is difficult. More research and clinical trials are needed to develop effective therapies that manipulate autophagy for treating pituitary tumors.

Pituitary tumors, arising from the pituitary gland, can be classified as functioning or non-functioning based on their hormone production. Previous studies demonstrated that impairment of cellular processes, such as autophagy, a crucial cellular recycling mechanism, has been implicated in pituitary tumorigenesis and hormone dysregulation. This review comprehensively examines the intricate relationship between autophagy and pituitary tumors. We explore the multifaceted role of autophagy in cancer, highlighting its dual nature as both a tumor suppressor and a promoter depending on the context. We also discuss the specific mechanisms of autophagy, including macroautophagy, mitophagy, crinophagy, and their relevance to pituitary tumorigenesis and hormone regulation. Furthermore, we analyze the current literature regarding the impact of various therapeutic interventions in pituitary tumor cells, with both autophagy-promoting and autophagy-inhibiting strategies. We address the challenges in interpreting autophagy activity and its complex interplay with hormone production. Current evidence suggests the potential of targeting autophagy as a therapeutic approach for pituitary tumors, emphasizing further research and clinical trials to determine the optimal strategy for individual patients and improve long-term outcomes.

## Full-text entities

- **Diseases:** cancer (MESH:D009369), tumorigenesis (MESH:D063646), dysregulation (MESH:D021081), Pituitary Tumors (MESH:D010911)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12070981/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12070981/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12070981/full.md

---
Source: https://tomesphere.com/paper/PMC12070981